Purpose
to develop and clinically test economically donor-friendly adjuvanted trivalent Inactivated Polio virus (IPV) vaccines with reduced IPV doses
Grantee
Division
Global Development,
Global Health
Date
OCTOBER 2013
Region served
GLOBAL
Committed amount
$36,537,523
Grant topic
Discovery and Translational Sciences,
Polio,
Vaccine Development
Duration (months)
110
Grantee location
Copenhagen S, Denmark
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.